CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 125 enrolled
Drug / intervention
TECNIS® Toric IIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04327518
NCT04327518N/ACompleted
CompareCT.gov

Clinical Investigation of Rotational Stability of the TECNIS® Toric II Intraocular Lens

Johnson & Johnson Surgical Vision, Inc.·interventional·Posted Mar 31, 2020·Updated Jun 1, 2022

In Brief

A clinical study evaluating TECNIS® Toric II for Cataract and Corneal Astigmatism. Completed, enrolled 125 participants across 7 sites.

Detailed Summary

This is a prospective, multicenter, single-arm, open-label clinical study of the commercially available TECNIS Toric II IOL. The study will be conducted in up to 192 subjects needing unilateral or bilateral cataract surgery in up to 8 sites in United States (US). The subjects will be followed for up to 3-months postoperatively.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract, Corneal Astigmatism
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMar 31, 2020
Enrollment StartJun 11, 2020
Primary CompletionApr 6, 2021
Study CompletionJun 1, 2021
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 6.3 years ago

Interventions

TECNIS® Toric IIdevice

Toric Intraocular Lens